Literature DB >> 22526452

Fetal growth restriction: current knowledge to the general Obs/Gyn.

Luciano Marcondes Machado Nardozza1, Edward Araujo Júnior, Maurício Mendes Barbosa, Ana Carolina Rabachini Caetano, Desireé Ji Re Lee, Antonio Fernandes Moron.   

Abstract

BACKGROUND: Fetal growth restriction (FGR) is a condition that affects 5-10 % of gestations, and it is the second primary cause of perinatal mortality. In this review the most recent knowledge about FGR is presented focusing on its concept, etiology, classification, diagnosis, management, and prognosis.
METHODS: Searches were conducted in Pubmed, Embase and Lilacs database using the term fetal growth restriction.
RESULTS: FGR is classified as type I (symmetric), manifested early, in which there is a proportional reduction of all fetal parts, generally associated with chromosome abnormalities; type II (asymmetric), with late onset, in which there is a more accentuated reduction of the abdomen, generally related to placental insufficiency; and type III (mixed), with early manifestation, resulting from infections or exposure to toxic agents. Diagnosis may be clinical, although ultrasound associated with arterial and venous Doppler is essential for diagnosis and follow-up. Currently there is no treatment capable of controlling FGR, and the moment of interruption of pregnancy is of vital importance in order to protect maternal and fetal interests.
CONCLUSION: Early diagnosis of FGR is very important, because it permits the etiological identification and adequate monitoring of fetal vitality, minimizing the risks related to prematurity and intrauterine hypoxia.

Entities:  

Mesh:

Year:  2012        PMID: 22526452     DOI: 10.1007/s00404-012-2330-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  19 in total

Review 1.  Programming of maternal and offspring disease: impact of growth restriction, fetal sex and transmission across generations.

Authors:  Jean N Cheong; Mary E Wlodek; Karen M Moritz; James S M Cuffe
Journal:  J Physiol       Date:  2016-04-24       Impact factor: 5.182

2.  Elemental Metabolomics for Prediction of Term Gestational Outcomes Utilising 18-Week Maternal Plasma and Urine Samples.

Authors:  Daniel R McKeating; Vicki L Clifton; Cameron P Hurst; Joshua J Fisher; William W Bennett; Anthony V Perkins
Journal:  Biol Trace Elem Res       Date:  2020-04-01       Impact factor: 3.738

3.  Assessment of in vivo fetal growth and placental vascular function in a novel intrauterine growth restriction model of progressive uterine artery occlusion in guinea pigs.

Authors:  Emilio A Herrera; René Alegría; Marcelo Farias; Farah Díaz-López; Cherie Hernández; Ricardo Uauy; Timothy R H Regnault; Paola Casanello; Bernardo J Krause
Journal:  J Physiol       Date:  2016-02-02       Impact factor: 5.182

4.  Impact of HAART Therapy and HIV Infection over Fetal Growth-An Anthropometric Point of View.

Authors:  Daniela Roxana Matasariu; Mircea Onofriescu; Elena Mihalceanu; Carmina Mihaiela Schaas; Iuliana Elena Bujor; Alexandra Maria Tibeica; Alexandra Elena Cristofor; Alexandra Ursache
Journal:  Microorganisms       Date:  2022-05-30

Review 5.  Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications.

Authors:  Marthe Tsochandaridis; Laurent Nasca; Caroline Toga; Annie Levy-Mozziconacci
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

6.  Disproportionate fetal growth and the risk for congenital cerebral palsy in singleton births.

Authors:  Elani Streja; Jessica E Miller; Chunsen Wu; Bodil H Bech; Lars Henning Pedersen; Diana E Schendel; Peter Uldall; Jørn Olsen
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

7.  Diagnosis of fetal growth restriction in perinatal deaths using brain to liver weight ratios.

Authors:  Alexandre S Stephens; Jason P Bentley; Lee K Taylor; Susan M Arbuckle
Journal:  Pathology       Date:  2015-01       Impact factor: 5.306

8.  miR-141 contributes to fetal growth restriction by regulating PLAG1 expression.

Authors:  Qiuqin Tang; Wei Wu; Xia Xu; Lu Huang; Qiong Gao; Huijuan Chen; Hong Sun; Yankai Xia; Jiahao Sha; Xinru Wang; Daozhen Chen; Qian Xu
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

Review 9.  The placental pursuit for an adequate oxidant balance between the mother and the fetus.

Authors:  Emilio A Herrera; Bernardo Krause; German Ebensperger; Roberto V Reyes; Paola Casanello; Mauro Parra-Cordero; Anibal J Llanos
Journal:  Front Pharmacol       Date:  2014-06-24       Impact factor: 5.810

10.  Role for the thromboxane A2 receptor β-isoform in the pathogenesis of intrauterine growth restriction.

Authors:  Katie L Powell; Veronica Stevens; Dannielle H Upton; Sharon A McCracken; Ann M Simpson; Yan Cheng; Vitomir Tasevski; Jonathan M Morris; Anthony W Ashton
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.